Search Results 201-210 of 17051 for peptide stacks

  1. Hematology - Clinical trials

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. A Study To Test Single And Multiple Doses Of MER511 Given To Adults With Graves' Disease - Mayo Clinic

    The purpose of this study is to evaluate how well MER511 is tolerated and what side effects may occur in adults who have Graves' disease. The study drug will be ...

  3. Short-Wave Near Infrared (SWIR) Imaging System For Characterizing Lymphatic Anatomy - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...

  4. Why choose Mayo Clinic for pancreatic adenocarcinoma

    ... . VID-20482361. Home; Why choose Mayo Clinic for pancreatic adenocarcinoma. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of ...

  5. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

  6. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  7. Sclerosing mesenteritis - Mayo Clinic

    Carol Bolton discusses her experience receiving treatment for sclerosing mesenteritis at Mayo Clinic. Share · Tweet . VID-20090416.

  8. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea - Mayo Clinic

    A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), ...

  9. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

    This study consists of two parts: Part A (dose escalation stage) and Part B (dose expansion stage). The study includes screening, treatment and follow-up ...

  10. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.